News & Announcements
Precision NanoSystems announces partnership with Fujifilm for the development and GMP manufacturing of nanoparticle based therapeutics
Vancouver BC, March 23, 2020 Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI’s NanoAssemblr technology and complete suite of instruments for Fujifilm’ [...]
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc. has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. Asuragen’s proprietary Armor [...]
RareCyte announces the first blood-to-result PD-L1 Circulating Tumor Cell Assay
Seattle, WA, February 27, 2020 – RareCyte announces a new liquid biopsy blood test for programmed death-ligand 1 (PD-L1), enabling customers to evaluate PD-L1 expression on circulating tumor cells (CTCs) with industry leading sensitivity. PD-L1 is a biomarker that directs checkpoint inhibitor immuno [...]
Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19
Active Motif Shanghai (a subsidiary of Active Motif, Inc.), in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic™ screening technology to isolate antibodies from patients recovering from 2019 Coronavirus related pneumonia (COVID-19). Th [...]
FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
The U.S. Food and Drug Administration today authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome (FXS), the most common known cause of inherited developmental delay and intellectual disability. The test is intended as an aid in diagnosing FXS and is to be [...]
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
MADISON, WI--Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration will leverage Nimble’s proprietary peptide [...]
Carterra® Closes Financing Round For Continued Growth of the LSA® Platform for Next Generation Antibody Discovery
Additional Resources Will Support New Product Development and Global Expansion SALT LAKE CITY, UTAH, USA (January 14, 2020) – Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participat [...]